Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.23
- Piotroski Score 4.00
- Grade N/A
- Symbol (AGE)
- Company AgeX Therapeutics, Inc.
- Price $11.10
- Changes Percentage (-11.9%)
- Change -$1.5
- Day Low $11.10
- Day High $12.59
- Year High $35.17
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/21/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$482.53
- Trailing P/E Ratio -0.02300375106211
- Forward P/E Ratio -0.02300375106211
- P/E Growth -0.02300375106211
- Net Income $-14,803,000
Income Statement
Quarterly
Annual
Latest News of AGE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ares Management Expands with $3.7 Billion GCP International Acquisition
Ares Management Corporation is acquiring GLP Capital Partners Limited's international business, GCP International, for $3.7 billion, aiming to expand its real estate platform....
By Yahoo! Finance | 1 hour ago -
Mortgage refinancings fall as average rates move higher
Homeowners are refraining from refinancing mortgages due to rising rates, with applications dropping by 9%. Purchase activity has plateaued, influenced by higher mortgage rates and revised expectation...
By Yahoo! Finance | 1 hour ago -
Should you refinance your mortgage now as rates drop?
Many U.S. homeowners are considering refinancing their mortgages due to lower rates and potential savings. Factors to consider include rate reduction, term adjustments, equity, and credit score. Shopp...
By Yahoo! Finance | 2 hours ago
